Too dangerous to ignore: Self-tolerance and the control of ignorant autoreactive T cells

Immunology and Cell Biology

Volumn 86, Issue 2, 2008, Pages 146-152

  Parish, Ian A ^a   Heath, William R ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Autoimmunity; Ignorance; T cells; Tolerance

Indexed keywords

ANTIGEN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL ACTIVATION; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; MEDICAL LITERATURE; NONHUMAN; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPHOCYTE ACTIVATION; SELF TOLERANCE; T-LYMPHOCYTE SUBSETS;

EID: 39749094451     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100161     Document Type: Review

References (71)

1. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol 2005; 5: 772-782.
2. Liu GY, Fairchild PJ, Smith RM, Prowle JR, Kioussis D, Wraith DC. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 1995; 3: 407-415.
3. Bouneaud C, Kourilsky P, Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 2000; 13: 829-840.
4. Zehn D, Bevan MJ. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity 2006; 25: 261-270.
5. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2: 1032-1039.
6. Kyewski B, Derbinski J. Self-representation in the thymus: an extended view. Nat Rev Immunol 2004; 4: 688-698.
7. Allen S, Read S, DiPaolo R, McHugh RS, Shevach EM, Gleeson PA et al. Promiscuous thymic expression of an autoantigen gene does not result in negative selection of pathogenic T cells. J Immunol 2005; 175: 5759-5764.
8. Walker LS, Abbas AK. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2002; 2: 11-19.
9. Miller JF, Morahan G, Allison J. Extrathymic acquisition of tolerance by T lymphocytes. Cold Spring Harb Symp Quant Biol 1989; 54 (Part 2): 807-813.
10. Jolicoeur C, Hanahan D, Smith KM. T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci USA 1994; 91: 6707-6711.
11. Liston A, Lesage S,Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003; 4: 350-354.
12. Heath WR, Allison J, Hoffmann MW, Schonrich G, Hammerling G, Arnold B et al. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 1992; 359: 547-549.
13. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B et al. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65: 305-317.
14. Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991; 65: 319-331.
15. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346: 183-187.
16. Jingwu Z, Medaer R, Hashim GA, Chin Y, van den Berg-Loonen E, Raus JC. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann Neurol 1992; 32: 330-338.
17. Kerlero de Rosbo N, Milo R, Lees MB, Burger D, Bernard CC, Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 1993; 92: 2602-2608.
18. Markovic-Plese S, Fukaura H, Zhang J, al-Sabbagh A, Southwood S, Sette A et al. Tcell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol 1995; 155: 982-992.
19. Lohmann T, Leslie RD, Londei M. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J Autoimmun 1996; 9: 385-389.
20. Semana G, Gausling R, Jackson RA, Hafler DA. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects. J Autoimmun 1999; 12: 259-267.
21. Takahashi K, Honeyman MC, Harrison LC. Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific. Clin Immunol 2001; 99: 360-364.
22. Arbour N, Lapointe R, Saikali P, McCrea E, Regen T, Antel JP. A new clinically relevant approach to expand myelin specific T cells. J Immunol Methods 2006; 310: 53-61.
23. Schonrich G, Kalinke U, Momburg F, Malissen M, Schmitt-Verhulst AM, Malissen B et al. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991; 65: 293-304.
24. Schonrich G, Momburg F, Malissen M, Schmitt-Verhulst AM, Malissen B, Hammerling GJ et al. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol 1992; 4: 581-590.
25. Lo D, Reilly CR, Scott B, Liblau R, McDevitt HO, Burkly LC. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes. Eur J Immunol 1993; 23: 1693-1698.
26. Forster I, Lieberam I. Peripheral tolerance of CD4T cells following local activation in adolescent mice. Eur J Immunol 1996; 26: 3194-3202.
27. Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996; 184: 923-930.
28. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR. Class I-restricted crosspresentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997; 186: 239-245.
29. Kurts C, Sutherland RM, Davey G, Li M, Lew AM, Blanas E et al. CD8T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci USA 1999; 96: 12703-12707.
30. Morgan DJ, Kreuwel HT, Sherman LA. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol 1999; 163: 723-727.
31. Belz GT, Behrens GM, Smith CM, Miller JF, Jones C, Lejon K et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 2002; 196: 1099-1104.
32. Vezys V, Olson S, Lefrancois L. Expression of intestine-specific antigen reveals novel pathways of CD8T cell tolerance induction. Immunity 2000; 12: 505-514.
33. Azukizawa H, Kosaka H, Sano S, Heath WR, Takahashi I, Gao XH et al. Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 2003; 33: 1879-1888.
34. Waithman J, Allan RS, Kosaka H, Azukizawa H, Shortman K, Lutz MB et al. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J Immunol 2007; 179: 4535-4541.
35. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med 1998; 187: 1555-1564.
36. + T cells. J Exp Med 1997; 185: 405-414.
37. + T cells. J Immunol 2007; 178: 2094-2103.
38. Kurts C, Miller JF, Subramaniam RM, Carbone FR, Heath WR. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 1998; 188: 409-414.
39. Kurts C, Cannarile M, Klebba I, Brocker T. Dendritic cells are sufficient to cross-present self-antigens to CD8T cells in vivo. J Immunol 2001; 166: 1439-1442.
40. Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, Homann D et al. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity 2002; 16: 169-181.
41. Turley S, Poirot L, Hattori M, Benoist C, Mathis D. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med 2003; 198: 1527-1537.
42. Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998; 279: 1344-1347.
43. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999; 283: 1335-1339.
44. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
45. Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
46. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995.
47. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
48. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255.
49. Shi Y, Zheng W, Rock KL. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Natl Acad Sci USA 2000; 97: 14590-14595.
50. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521.
51. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195: 99-111.
52. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168: 5233-5239.
53. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P et al. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998; 161: 4467-4471.
54. Feng H, Zeng Y, Graner MW, Katsanis E. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood 2002; 100: 4108-4115.
55. Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 2004; 200: 1359-1370.
56. Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS et al. Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. Immunity 2006; 24: 787-799.
57. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997; 3: 1133-1136.
58. Katz-Levy Y, Neville KL, Padilla J, Rahbe S, Begolka WS, Girvin AM et al. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice. J Immunol 2000; 165: 5304-5314.
59. Vezys V, Lefrancois L. Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol 2002; 169: 6677-6680.
60. + T cells to cause immunopathology. J Exp Med 1998; 187: 763-774.
61. Waldner H, Collins M, Kuchroo VK. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 2004; 113: 990-997.
62. Hamilton-Williams EE, Lang A, Benke D, Davey GM, Wiesmuller KH, Kurts C. Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J Immunol 2005; 174: 1159-1163.
63. Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006; 440: 808-812.
64. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med 2002; 196: 1079-1090.
65. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000; 191: 435-444.
66. Li M, Davey GM, Sutherland RM, Kurts C, Lew AM, Hirst C et al. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 2001; 166: 6099-6103.
67. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191: 423-434.
68. Albert ML, Jegathesan M, Darnell RB. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2001; 2: 1010-1017.
69. Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002; 196: 1091-1097.
70. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358: 155-157.
71. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2002; 2: 85-95.